Phathom Pharmaceuticals, Inc.

NASDAQ:PHAT

Biotechnology

Healthcare
$5.30 -2.45%

-$0.27 today

Market cap
$430.84M
Beta
0.51
P/E (TTM)
-5.6
EPS (TTM)
-$1.92
52W Low $7.61High $18.31

Volume 1.67M

Average 1.21M

Balance Sheet

Inspect the capital base behind the business.

Assets

$259.15M

FY 2025 · Annual

-31.5% YoY

Liabilities

$697.32M

FY 2025 · Annual

+10.4% YoY

Equity

-$438.17M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents183.26M155.39M381.39M297.26M129.97M
Short-term Investments00000
Net Receivables001.64M38.8M78.13M
Inventory001.21M3.21M5.52M
Other Current Assets3.27M5.13M13.19M20.87M15.35M
Total Current Assets186.53M160.51M397.43M360.13M228.97M
Property, Plant & Equipment (Net)2.56M3.49M3.62M2.09M3.67M
Goodwill00000
Intangible Assets00000
Long-term Investments0505K02.86M0
Tax Assets00000
Other Non-current Assets341K299K12.79M13.23M26.51M
Total Non-current Assets2.91M4.3M16.41M18.18M30.18M
Total Assets189.43M164.81M413.84M378.32M259.15M
Account Payables5.15M10M12.6M10.51M4.98M
Short-term Debt00019.78M648K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.34M8.45M20.43M54.94M126.41M
Total Current Liabilities18.92M26.24M38.78M85.73M132.04M
Long-term Debt89.67M95.26M137.84M534.67M209.09M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities7.5M117.03M309.52M11.5M354.12M
Total Non-current Liabilities98.35M213.39M447.82M546.17M565.27M
Total Liabilities117.28M239.62M486.6M631.9M697.32M
Common Stock3K3K5K6K6K
Retained Earnings(529.37M)(727.09M)(928.69M)(1.26B)(1.48B)
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity72.16M(74.81M)(72.76M)(253.58M)(438.17M)
Total Debt91.34M97.07M139.03M554.95M211.8M
Net Debt(91.92M)(58.32M)(242.36M)257.68M81.83M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$180.9M
Receivables$80.7M
Inventory$6.5M
Other Current$8.4M
Total Current Assets$276.6M
PP&E (Net)$3.5M
Other Non-current$25.0M
Total Non-current Assets$28.5M
Total Assets$305.1M

Analysis

Selected assets total $305.1M for Latest. The largest visible component is Cash & Equivalents at $180.9M, about 59.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 10, 2026
SC 13D/ASC 13D/A filingNov 2, 2026
10-QQuarterly reportOct 29, 2026
8-KCurrent reportOct 29, 2026
8-KCurrent reportOct 26, 2026

How much cash does PHAT have?

Phathom Pharmaceuticals, Inc. (PHAT) reported $129.97M in cash and equivalents in fiscal 2025.

How much debt does PHAT carry?

Phathom Pharmaceuticals, Inc. (PHAT) reported $211.80M of total debt, with net debt of $81.83M.